1. Home
  2. ASMB vs FSP Comparison

ASMB vs FSP Comparison

Compare ASMB & FSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • FSP
  • Stock Information
  • Founded
  • ASMB 2005
  • FSP 1981
  • Country
  • ASMB United States
  • FSP United States
  • Employees
  • ASMB N/A
  • FSP N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • FSP Real Estate Investment Trusts
  • Sector
  • ASMB Health Care
  • FSP Real Estate
  • Exchange
  • ASMB Nasdaq
  • FSP Nasdaq
  • Market Cap
  • ASMB 196.9M
  • FSP 165.9M
  • IPO Year
  • ASMB 2010
  • FSP N/A
  • Fundamental
  • Price
  • ASMB $27.47
  • FSP $1.46
  • Analyst Decision
  • ASMB Strong Buy
  • FSP
  • Analyst Count
  • ASMB 4
  • FSP 0
  • Target Price
  • ASMB $42.33
  • FSP N/A
  • AVG Volume (30 Days)
  • ASMB 156.9K
  • FSP 403.7K
  • Earning Date
  • ASMB 11-06-2025
  • FSP 10-28-2025
  • Dividend Yield
  • ASMB N/A
  • FSP 2.67%
  • EPS Growth
  • ASMB N/A
  • FSP N/A
  • EPS
  • ASMB N/A
  • FSP N/A
  • Revenue
  • ASMB $33,247,000.00
  • FSP $111,879,000.00
  • Revenue This Year
  • ASMB $14.32
  • FSP $4.36
  • Revenue Next Year
  • ASMB N/A
  • FSP $0.81
  • P/E Ratio
  • ASMB N/A
  • FSP N/A
  • Revenue Growth
  • ASMB 54.77
  • FSP N/A
  • 52 Week Low
  • ASMB $7.75
  • FSP $1.36
  • 52 Week High
  • ASMB $27.90
  • FSP $2.21
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 65.33
  • FSP 27.54
  • Support Level
  • ASMB $23.21
  • FSP $1.58
  • Resistance Level
  • ASMB $27.17
  • FSP $1.60
  • Average True Range (ATR)
  • ASMB 1.70
  • FSP 0.05
  • MACD
  • ASMB 0.29
  • FSP -0.02
  • Stochastic Oscillator
  • ASMB 97.82
  • FSP 4.17

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.

Share on Social Networks: